| Address: | 600 Gateway Blvd #100, South San Francisco, CA 94080, USA |
|---|---|
| Postal code: | 94080 |
| Phone: | (650) 294-4461 |
| Website: | https://www.r2mpharma.com/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about R2M Pharma, Inc., use the form below and your opinion, advice or comment will appear in this space.
Find and reach R2M Pharma, Inc.'s employees by department, seniority, title, and much more. R2M Pharma is a fast growing biotechnology research organization devoted to the discovery of high quality small molecules preclinical development compounds for the treatment of unmet medical indications.
Free and open company data on Delaware (US) company R2M PHARMA, INC. (company number 6355242). R2M PHARMA, INC.
Free and open company data on California (US) company R2M PHARMA, INC. (company number C4007117), 171 OYSTER POINT BLVD., SUITE 501 SOUTH SAN FRANCISCO CA 94080.
Get information, directions, products, services, phone numbers, and reviews on R2m Pharma in South San Francisco, undefined Discover more Commercial Physical and Biological Research companies in South San Francisco on Manta.com. Is this your listing? R2m Pharma, Inc is an unclaimed page.
Get directions, reviews and information for R2M Pharma, Inc in South San Francisco, CA. R2M Pharma, Inc.
R2M Pharma, Inc. | 457 followers on LinkedIn. R2M Pharma is a fast growing biotechnology research organization devoted to the discovery of high quality small molecules preclinical development compounds for the treatment of unmet medical indications.
About us. The SFJ Pharmaceuticals Group is a Specialty Pharma Company deploying a new business model for the clinical development and registration of pharmaceutical products. Established in 2009, SFJ provides a financially advantageous and creative alternative approach to partnering.
R2M Pharma, Inc.
R2M Pharma, Inc. Jun 2017 - Present3 years 5 months. San Francisco Bay Area. Design and synthesis of modulators in neuroprotective therapeutics potentially to treat Alzheimer's disease and related symptoms. Martin Holan. Scientist at R2M Pharma, Inc. San Francisco Bay Area.
As a scientist at R2M Pharma, made key contributions to small molecule drug discovery programs in the areas of cardiovascular and CNS diseases resulting in 3 patents. Demonstrated proficiency in design and synthesis of small molecules, SAR exploration and hit-to-lead optimization campaigns...